HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography: A Novel Prothrombotic Marker of Coronary Artery Stent Restenosis.

AbstractBACKGROUND AND OBJECTIVE:
In-stent restenosis (ISR) is a limitation of percutaneous coronary intervention and has been linked to specific clinical and angiographic variables. We aimed to simultaneously assess thrombosis biomarkers and lipid levels in patients with and without ISR.
METHODS:
Consecutive patients (n = 170) with a history of coronary stenting undergoing elective angiography were studied. Blood samples for thrombelastography, light transmittance aggregometry, and lipid levels were obtained prior to cardiac catheterization.
RESULTS:
Sixty-nine patients (41%) had ISR (>50% luminal diameter stenosis). Among patients with ISR, 40 (58%) had ISR in more than one stent bed. Patients with ISR were more often female (37.7% vs. 21.8%, P = 0.04), had higher thrombin-induced platelet-fibrin clot strength (TIP-FCS) (69.9 mm vs. 65.6 mm, P < 0.001), and a higher ApoB/A1 ratio (0.65 vs. 0.59, P = 0.03). In patients on dual antiplatelet therapy (n = 86), there were no differences in ADP-, arachidonic acid-, and collagen-induced platelet aggregation between groups. The frequency of patients with ISR increased with TIP-FCS quartiles and by ROC analysis, TIP-FCS = 67.0 mm was the cutpoint for identification of ISR (AUC = 0.80 (95%CI 0.73-0.87, P < 0.0001). By multivariate analysis, TIP-FCS ≥67.0 mm strongly associated with ISR (OR = 7.3, P = 0.004).
CONCLUSION:
Patients with ISR identified at the time of cardiac catheterization have a prothrombotic phenotype indicated by high TIP-FCS, a novel marker. Studies to confirm the prognostic utility of high TIP-FCS for the development of ISR are ongoing.
AuthorsKevin P Bliden, Udaya S Tantry, Martin G Gesheff, Christopher J Franzese, Shachi Pandya, Peter P Toth, Denny P Mathew, Rahul Chaudhary, Paul A Gurbel
JournalJournal of interventional cardiology (J Interv Cardiol) Vol. 29 Issue 2 Pg. 168-78 (Apr 2016) ISSN: 1540-8183 [Electronic] United States
PMID26822493 (Publication Type: Journal Article)
Copyright© 2016, Wiley Periodicals, Inc.
Chemical References
  • Biomarkers
  • Lipids
  • Fibrin
  • Thrombin
Topics
  • Aged
  • Biomarkers (blood)
  • Blood Platelets (physiology)
  • Coronary Restenosis (blood, etiology)
  • Coronary Vessels (diagnostic imaging)
  • Female
  • Fibrin (analysis)
  • Humans
  • Lipids (blood)
  • Logistic Models
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention (adverse effects)
  • Platelet Aggregation (physiology)
  • ROC Curve
  • Stents (adverse effects)
  • Thrombelastography (methods)
  • Thrombin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: